FENNEC PHARMACEUTICALS INC. (FENC) insider trading

By person

13 insiders · 196 transactions

1.1×

Jeffrey Hackman holds only 1.1 times base salary in stock. $682.25K of shares against $586.34K in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Hackman last reported holding, valued at $10.29, the price Common Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Southpoint Capital Advisors LP entity

10% owner

$500.00K (1)

$10.34M (7)

−$9.84M

6,821,955

19.45%

$70.20M

−15.5%

Manchester Management Pr, LLC entity

10% owner

$662.55K (38)

$10.35M (31)

−$9.69M

2,916,666

8.32%

$30.01M

−22.8%

SPA Essetifin

10% owner

$7.30M (2)

—

+$7.30M

3,993,694

11.39%

$41.10M

+36.2%

Rosty Raykov

Former Director

— (1)

$3.83M (44) scheduled

−$3.83M

124,411

0.3548%

$1.28M

+66.9%

Robert Andrade

Chief Financial Officer

— (1)

$1.94M (11) scheduled

−$1.94M

248,558

0.7088%

$2.56M

—

Adrian Haigh

Chief Operating Officer

—

$1.51M (10) scheduled

−$1.51M

0.0000%

$0.00

—

Chris A Rallis

Director

—

$296.78K (18) scheduled

−$296.78K

63,077

0.1799%

$649.06K

—

Marco Maria Brughera

Director

—

$159.96K (1) scheduled

−$159.96K

0.0000%

$0.00

—

Pierre Sargis Sayad

Chief Medical Officer

—

$146.16K (1)

−$146.16K

13,701

0.0391%

$140.98K

—

Jeffrey S. Hackman

Chief Executive Officer

$104.60K (2)

—

+$104.60K

70,844

0.2020%

$728.98K

—

Khalid Islam

Director

—

213,825

0.6098%

$2.20M

—

Christiana Marie Cioffi

Chief Strategy Officer

—

28,902

0.0824%

$297.40K

—

Terry L Evans

Chief Commercial Officer

—

24,181

0.0690%

$248.82K

—

FENNEC PHARMACEUTICALS INC.

What the insiders did Net selling

By person